Delivery Order SPE2DB24D2205-SPE2DB25FEHSW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ofev 150 mg capsules (60-count units) valued at $17,181.16. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is due for completion by September 26, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $17,220.86 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ofev 100 mg capsules (60-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 23, 2025. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,590.58 on August 19, 2025, for the supply of Ofev 150 mg capsules (60-count). This is a firm fixed price delivery order with a completion date of September 10, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Ofev 150 mg capsules (60-count units) with a ceiling value of $17,181.16. This firm fixed-price delivery order, which is not associated with any set-aside program, is scheduled for completion by July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ofev 150 mg capsules in a quantity of 60 units. This firm fixed-price delivery order, valued at $8,590.58, represents a non-competitive award and is scheduled for completion by September 22, 2025. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ofev 150 mg capsules (60-count units). The contract represents a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This delivery order is issued under...
- The Defense Logistics Agency awarded a $8,590.58 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of OFEV 150 mg capsules (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Ofev 150 mg capsules (60-unit packages) with a ceiling value of $8,590.58. This firm fixed-price delivery order is scheduled for completion by August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under AmerisourceBergen's existing contract vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $17,260.58 to AmerisourceBergen Drug Corp for 60-count bottles of Ofev 100 mg capsules on September 17, 2025, with an ultimate completion date of October 8, 2025. This non-set-aside, firm fixed-price contract represents a competitive award to the pharmaceutical distributor and represents medical supply procurement for federal healthcare needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ofev 150 mg capsules (60-count units) under a firm fixed-price contract valued at $8,590.58, with completion targeted for August 20, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHSWDelivery Order
The Defense Logistics Agency awarded a $25,771.74 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ofev 150 mg capsules (60-count units). The contract is scheduled for completion by October 8, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order representing a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's military healthcare systems. This delivery order derives from AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its established capability to meet competitive federal procurement requirements across diverse pharmaceutical therapeutic domains and delivery scales, positioning it as a primary vendor for Defense Health Agency and related government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.8k | 9/17/25 |